UBS Lux Equity Fund Biotech USD vs Kvartil Liquid Private Assets A

UBS Lux Equity Fund Biotech USD vs Kvartil Liquid Private Assets A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Kvartil Liquid Private Assets A

  • Security

    Kvartil Liquid Private Assets A

  • Fee

    1.50%

  • ISIN

    SE0019352485

  • Holdings

    13

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Kvartil Liquid Private Assets A, we have 14 holdings where Investor is the largest holding (32.84), followed by Lundbergföretagen (14.26) and Kinnevik (10.3).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Kvartil Liquid Private Assets A.

UBS Lux Equity Fund Biotech USD Kvartil Liquid Private Assets A
1. Regeneron Pharmaceuticals Inc
10.04 %		 1. Investor B
Sweden
32.84 %
2. Moderna Inc
9.21 %		 2. Lundbergföretagen B
Sweden
14.26 %
3. Gilead Sciences Inc
USA
4.66 %		 3. Kinnevik B
Sweden
10.3 %
4. BioNTech SE
4.13 %		 4. Latour B
Sweden
10.19 %
5. Karuna Therapeutics Inc
3.75 %		 5. Sampo Oyj A
Finland
9.33 %
- 6. Aker ASA
Norway
9.28 %
- 7. Groupe Bruxelles Lambert SA
France
8.79 %
- 8. Exor NV
Netherlands
8.76 %
- 9. Creades A
Sweden
8.43 %
- 10. SEB A
Sweden
7.02 %
- 11. Ratos B
Sweden
4.87 %
- 12. Bure Equity AB
Sweden
4.6 %
- 13. VNV Global AB
Sweden
2.84 %

The list of fund holdings was last updated on September 10, 2025.